Turkish Journal of Pharmaceutical Sciences

Scope & Guideline

Unlocking the Potential of Pharmaceutical Research

Introduction

Immerse yourself in the scholarly insights of Turkish Journal of Pharmaceutical Sciences with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1304-530x
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2006 to 2024
AbbreviationTURK J PHARM SCI / Turk. J. Pharm. Sci.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The Turkish Journal of Pharmaceutical Sciences focuses on the intersection of pharmaceutical sciences and health, emphasizing research that contributes to better drug development, therapeutic strategies, and patient care. The journal serves as a platform for disseminating innovative research findings and methodologies in various pharmaceutical disciplines.
  1. Pharmacotherapy and Clinical Pharmacy:
    The journal emphasizes studies on pharmacotherapy, particularly involving clinical pharmacists' roles in optimizing drug therapy, medication adherence, and management of drug-related problems.
  2. Drug Formulation and Delivery Systems:
    Research on novel drug formulations, including nanocarriers, gels, and other delivery systems, is a core focus, highlighting advancements in drug bioavailability and therapeutic efficacy.
  3. Natural Products and Phytochemistry:
    The journal publishes articles on the pharmacological properties of natural compounds, herbal medicines, and their potential therapeutic applications, reflecting a growing interest in phytotherapy.
  4. Analytical and Quality Control Methods:
    There is a significant emphasis on the development and validation of analytical methods for drug analysis, stability testing, and quality control in pharmaceuticals.
  5. Pharmacoepidemiology and Pharmacovigilance:
    Studies assessing drug safety, adverse effects, and public health impacts of medications are integral to the journal's scope, particularly in the context of emerging health crises like the COVID-19 pandemic.
  6. Biopharmaceuticals and Biotechnology:
    Research on biopharmaceuticals, including monoclonal antibodies and gene therapy, reflects the journal’s commitment to innovative therapeutic approaches.
The Turkish Journal of Pharmaceutical Sciences has shown a dynamic evolution in its research themes, with several emerging topics gaining traction over recent years. These trends reflect the journal's responsiveness to contemporary challenges in healthcare and pharmaceutical sciences.
  1. COVID-19 Research and Therapeutics:
    There is an increasing trend in publications related to COVID-19, including studies on vaccine efficacy, treatment protocols, and the impact of the pandemic on healthcare systems.
  2. Nanotechnology in Drug Delivery:
    Research on nanotechnology applications in drug delivery systems is on the rise, showcasing innovative methods to enhance drug solubility and target specific tissues.
  3. Pharmacogenomics and Personalized Medicine:
    The integration of pharmacogenomic studies, aiming to tailor individual drug therapies based on genetic profiles, is emerging as a significant focus area.
  4. Digital Health and Telepharmacy:
    With advancements in technology, there is a growing interest in the role of digital health solutions and telepharmacy in improving patient outcomes and medication management.
  5. Sustainable Pharmaceutical Practices:
    Research on environmentally sustainable practices in pharmaceutical development, including biodegradable materials and green chemistry, is gaining prominence.
  6. Multidisciplinary Approaches to Drug Development:
    An increase in interdisciplinary studies that combine pharmaceutical sciences with biotechnology, engineering, and data science is evident, reflecting a collaborative approach to complex health challenges.

Declining or Waning

While the Turkish Journal of Pharmaceutical Sciences has maintained a robust focus on various pharmaceutical disciplines, certain themes appear to be declining in prominence. This may reflect shifting research priorities or advancements in methodologies that render previous topics less relevant.
  1. Traditional Pharmaceutical Education:
    There has been a noticeable decrease in studies focused solely on traditional aspects of pharmaceutical education, as the field evolves towards more practical, experiential learning approaches.
  2. Basic Pharmaceutical Chemistry:
    Research centered on fundamental chemistry principles without direct application to drug development or therapeutic use has seen a decline, as the journal prioritizes more applied research.
  3. Animal Testing Studies:
    With the growing emphasis on ethical research practices and alternative methods, studies solely relying on animal testing without clear translational relevance to human health are appearing less frequently.
  4. Conventional Drug Discovery Processes:
    Interest in traditional drug discovery methodologies is waning in favor of more innovative approaches such as computational drug design and high-throughput screening.
  5. Regulatory Affairs Focus:
    Papers focusing primarily on regulatory affairs without a direct link to practical implications for drug development and patient care are becoming less common, indicating a shift towards more integrative research.

Similar Journals

Journal of Young Pharmacists

Bridging Theory and Practice in Pharmacology
Publisher: INPHARM ASSOC, PHCOG NETISSN: 0975-1483Frequency: 4 issues/year

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

SAUDI PHARMACEUTICAL JOURNAL

Connecting researchers and professionals for impactful pharmaceutical advancements.
Publisher: ELSEVIERISSN: 1319-0164Frequency: 8 issues/year

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

Current Issues in Pharmacy and Medical Sciences

Illuminating current trends in pharmacy and biochemistry.
Publisher: SCIENDOISSN: 2084-980XFrequency: 4 issues/year

Current Issues in Pharmacy and Medical Sciences is a prominent open-access journal published by SCIENDO, dedicated to advancing knowledge and understanding in the fields of pharmacy, biochemistry, molecular biology, and medicine. With an ISSN of 2084-980X and an E-ISSN of 2300-6676, this journal provides a platform for researchers and academics to disseminate current findings and methodologies shaping the future of these disciplines. Since its inception in 2012 and having established itself as an open-access journal since 2014, Current Issues in Pharmacy and Medical Sciences has been committed to providing high-quality, peer-reviewed content that fosters innovation and scholarly collaboration, even as it currently ranks in the Q4 category across several key areas, including Pharmacology and Biochemistry. The journal's findings are particularly relevant to professionals and students aiming to stay abreast of the latest trends and issues impacting healthcare and pharmaceutical sciences. With future issues anticipated until 2024, this journal is positioned as a vital resource for anyone engaged in the pharmaceutical and medical fields and contributing to meaningful advancements.

PHARMACIA

Empowering innovation in pharmacy and pharmacology.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

Ars Pharmaceutica

Advancing pharmaceutical knowledge through open dialogue.
Publisher: UNIV GRANADA, EDITORIALISSN: 0004-2927Frequency: 4 issues/year

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

Indonesian Journal of Pharmacy

Pioneering insights in Indonesian pharmacy and beyond.
Publisher: UNIV GADJAH MADA, FAC FARMASIISSN: 2338-9486Frequency: 4 issues/year

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.

Indian Journal of Pharmaceutical Education and Research

Elevating standards in pharmaceutical education and research.
Publisher: ASSOC PHARMACEUTICAL TEACHERS INDIAISSN: 0019-5464Frequency: 4 issues/year

Indian Journal of Pharmaceutical Education and Research, published by the Association of Pharmaceutical Teachers of India, is a pivotal platform for scholarly discussion in the field of pharmacology, toxicology, and pharmaceutics. ISSN 0019-5464, this esteemed journal aims to foster the exchange of innovative research, clinical advancements, and educational practices within the pharmaceutical sciences community. As a Q3-ranked journal in its category as of 2023, it reflects a commitment to upholding the standards of academic excellence and contributes significantly to the ongoing development of pharmaceutical education. The journal is a valuable resource for researchers, professionals, and students, with content spanning various key areas including drug formulation, safety, and the latest trends in pharmaceutical education. By providing open access to its research and reviews, the journal ensures that vital information is disseminated widely, promoting collaboration and learning among stakeholders in the pharmaceutical sector. Based in Bangalore, India, the journal has been instrumental in highlighting regional research while fostering a global dialogue in pharmaceutical sciences. As it continues its journey from 2008 to 2024, it remains dedicated to impacting the field through rigorous peer-reviewed content and engaging with contemporary challenges in healthcare and education.

Istanbul Journal of Pharmacy

Empowering research, enhancing pharmacy practice.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Elevating pharmaceutical discourse in tropical regions.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Navigating the Complexities of Drug Formulation and Manufacturing
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-9045Frequency: 12 issues/year

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.